Aceso Life Science Group Limited (0474.HK)
HKD 0.03
(0.0%)
HKD 0.03
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 11 Million HKD | -13.14% |
| 2022 | 312 Million HKD | -0.95% |
| 2021 | 315 Million HKD | -8.96% |
| 2020 | 346 Million HKD | 17.03% |
| 2019 | 295.64 Million HKD | -7.47% |
| 2018 | 319.51 Million HKD | -3.18% |
| 2017 | 330.01 Million HKD | 59.96% |
| 2016 | 206.31 Million HKD | 58.72% |
| 2015 | 129.98 Million HKD | 113.45% |
| 2014 | 60.89 Million HKD | 51.03% |
| 2013 | 40.32 Million HKD | -64.16% |
| 2012 | 112.51 Million HKD | -21.36% |
| 2011 | 143.07 Million HKD | 17.18% |
| 2010 | 122.09 Million HKD | 25.84% |
| 2009 | 97.02 Million HKD | -41.73% |
| 2008 | 166.5 Million HKD | -5.82% |
| 2007 | 176.8 Million HKD | 12.97% |
| 2006 | 156.5 Million HKD | 3.61% |
| 2005 | 151.05 Million HKD | 15.68% |
| 2004 | 130.58 Million HKD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 Q1 | 16.5 Million HKD | -89.88% |
| 2023 FY | 271 Million HKD | -13.14% |
| 2023 Q4 | -11 Million HKD | 0.0% |
| 2023 Q3 | -11 Million HKD | -108.33% |
| 2023 Q2 | 132 Million HKD | 700.0% |
| 2022 Q2 | 183 Million HKD | 771.43% |
| 2022 Q1 | 21 Million HKD | -87.43% |
| 2022 Q3 | 82.5 Million HKD | -54.92% |
| 2022 Q4 | 163 Million HKD | 97.58% |
| 2022 FY | 312 Million HKD | -0.95% |
| 2021 Q1 | 48.5 Million HKD | -71.3% |
| 2021 Q3 | 36.5 Million HKD | -80.16% |
| 2021 Q2 | 184 Million HKD | 279.38% |
| 2021 Q4 | 167 Million HKD | 357.53% |
| 2021 FY | 315 Million HKD | -8.96% |
| 2020 FY | 346 Million HKD | 17.03% |
| 2020 Q4 | 169 Million HKD | 234.66% |
| 2020 Q1 | 61 Million HKD | -74.85% |
| 2020 Q2 | 227 Million HKD | 272.13% |
| 2020 Q3 | -125.5 Million HKD | -155.29% |
| 2019 Q4 | 242.53 Million HKD | 714.01% |
| 2019 Q1 | 27 Million HKD | -18.44% |
| 2019 Q2 | 157.54 Million HKD | 483.51% |
| 2019 Q3 | -39.5 Million HKD | -125.07% |
| 2019 FY | 295.64 Million HKD | -7.47% |
| 2018 FY | 319.51 Million HKD | -3.18% |
| 2018 Q4 | 33.1 Million HKD | 0.0% |
| 2018 Q1 | 54.62 Million HKD | -5.15% |
| 2018 Q2 | 54.62 Million HKD | 0.0% |
| 2018 Q3 | 33.1 Million HKD | -39.4% |
| 2017 Q1 | 67.62 Million HKD | 60.34% |
| 2017 Q4 | 57.59 Million HKD | 0.0% |
| 2017 Q3 | 57.59 Million HKD | -14.83% |
| 2017 Q2 | 67.62 Million HKD | 0.0% |
| 2017 FY | 330.01 Million HKD | 59.96% |
| 2016 Q2 | 17.04 Million HKD | 0.0% |
| 2016 Q3 | 42.17 Million HKD | 147.39% |
| 2016 Q1 | 17.04 Million HKD | -8.56% |
| 2016 Q4 | 42.17 Million HKD | 0.0% |
| 2016 FY | 206.31 Million HKD | 58.72% |
| 2015 FY | 129.98 Million HKD | 113.45% |
| 2015 Q2 | 2.41 Million HKD | 0.0% |
| 2015 Q4 | 18.64 Million HKD | 0.0% |
| 2015 Q3 | 18.64 Million HKD | 672.89% |
| 2015 Q1 | 2.41 Million HKD | 179.16% |
| 2014 Q1 | 319.5 Thousand HKD | -96.12% |
| 2014 Q2 | 319.5 Thousand HKD | 0.0% |
| 2014 Q3 | -3.04 Million HKD | -1053.68% |
| 2014 FY | 60.89 Million HKD | 51.03% |
| 2014 Q4 | -3.04 Million HKD | 0.0% |
| 2013 Q2 | 4.81 Million HKD | 0.0% |
| 2013 Q1 | 4.81 Million HKD | 115.61% |
| 2013 Q3 | 8.23 Million HKD | 71.17% |
| 2013 Q4 | 8.23 Million HKD | 0.0% |
| 2013 FY | 40.32 Million HKD | -64.16% |
| 2012 FY | 112.51 Million HKD | -21.36% |
| 2012 Q1 | 30.16 Million HKD | -15.66% |
| 2012 Q2 | 30.16 Million HKD | 0.0% |
| 2012 Q3 | -30.81 Million HKD | -202.14% |
| 2012 Q4 | -30.81 Million HKD | 0.0% |
| 2011 Q4 | 35.76 Million HKD | 0.0% |
| 2011 Q3 | 35.76 Million HKD | 17.18% |
| 2011 Q1 | 30.52 Million HKD | 0.0% |
| 2011 Q2 | 30.52 Million HKD | 0.0% |
| 2011 FY | 143.07 Million HKD | 17.18% |
| 2010 FY | 122.09 Million HKD | 25.84% |
| 2010 Q3 | 30.52 Million HKD | 25.84% |
| 2010 Q4 | 30.52 Million HKD | 0.0% |
| 2010 Q1 | 24.25 Million HKD | 0.0% |
| 2010 Q2 | 24.25 Million HKD | 0.0% |
| 2009 Q4 | 24.25 Million HKD | 0.0% |
| 2009 Q2 | 41.62 Million HKD | 0.0% |
| 2009 Q1 | 41.62 Million HKD | 0.0% |
| 2009 FY | 97.02 Million HKD | -41.73% |
| 2009 Q3 | 24.25 Million HKD | -41.73% |
| 2008 Q2 | 44.2 Million HKD | 0.0% |
| 2008 Q1 | 44.2 Million HKD | 0.0% |
| 2008 Q4 | 41.62 Million HKD | 0.0% |
| 2008 FY | 166.5 Million HKD | -5.82% |
| 2008 Q3 | 41.62 Million HKD | -5.82% |
| 2007 Q1 | 39.12 Million HKD | 0.0% |
| 2007 Q4 | 44.2 Million HKD | 0.0% |
| 2007 Q3 | 44.2 Million HKD | 12.97% |
| 2007 Q2 | 39.12 Million HKD | 0.0% |
| 2007 FY | 176.8 Million HKD | 12.97% |
| 2006 Q3 | 39.12 Million HKD | 3.61% |
| 2006 Q4 | 39.12 Million HKD | 0.0% |
| 2006 Q1 | 37.76 Million HKD | 0.0% |
| 2006 Q2 | 37.76 Million HKD | 0.0% |
| 2006 FY | 156.5 Million HKD | 3.61% |
| 2005 Q1 | 32.64 Million HKD | 0.0% |
| 2005 Q3 | 37.76 Million HKD | 15.68% |
| 2005 Q4 | 37.76 Million HKD | 0.0% |
| 2005 FY | 151.05 Million HKD | 15.68% |
| 2005 Q2 | 32.64 Million HKD | 0.0% |
| 2004 FY | 130.58 Million HKD | 0.0% |
| 2004 Q4 | 32.64 Million HKD | 0.0% |
| 2004 Q3 | 32.64 Million HKD | 0.0% |